Guillain-Barré syndrome (GBS) including Miller Fisher syndrome and other variants

Specialty: Neurology

Recommendations:

IVIG is recommended for symptoms of grade 3 severity (able to walk with aid) or greater; or symptoms less than grade 3 severity that are progressing.

Treatment should be given within 2 weeks of symptom onset.

Re-treatment for patients who do not respond may be considered.

Dose:

Adult: Total dose of 2 g/kg divided over 2 to 5 days.

Pediatric: Total dose of 2 g/kg divided over 2 days.

Repeat treatment with IVIG at 2 g/kg divided over 2 to 5 days.